Tag: Diffuse Midline Glioma

Home / Diffuse Midline Glioma

Categories

Chimerix’s Dordaviprone Receives FDA Priority Review for Recurrent H3 K27M-Mutant Diffuse Glioma

IntroductionChimerix, a prominent biopharmaceutical firm, has declared that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Dordaviprone (ONC201). The medic...
diffuse-midline-glioma

Dr. Zhang Wei: Leading Innovation in Epigenetic Therapy for Diffuse Midline Glioma at Tsinghua University

IntroductionDiffuse midline glioma (DMG) remains one of the most aggressive and devastating brain tumors in children and young adults. Surgical removal is often impossible due to its deep-seated midli...
diffuse-midline-glioma

Scan the code